Remi Bader and gastric sleeve surgery have become linked in public discussion, prompting many people to seek accurate clinical information about this procedure. A sleeve gastrectomy is one of the most commonly performed bariatric operations in the UK, involving the surgical removal of around 75–80% of the stomach to reduce food intake and appetite. Whether you are exploring this option for yourself or simply curious about the facts behind the headlines, this article explains how the procedure works, who qualifies on the NHS, what the risks and benefits are, and where to find trustworthy support and guidance.

What Is a Gastric Sleeve and How Does It Work?

A gastric sleeve removes 75–80% of the stomach laparoscopically, creating a small tube-shaped stomach that restricts food intake and reduces ghrelin levels to decrease appetite. It is a permanent, irreversible procedure indicated for clinically significant obesity.

Have any more questions about this? Message our pharmaceutical team to get more info →

A gastric sleeve, formally known as a sleeve gastrectomy, is a type of bariatric (weight loss) surgery in which approximately 75–80% of the stomach is surgically removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. The procedure is performed laparoscopically (keyhole surgery) under general anaesthetic and typically takes one to two hours. Because the remaining stomach is significantly smaller, patients feel full much more quickly after eating, which naturally reduces calorie intake.

Beyond the mechanical restriction of food intake, the gastric sleeve also has important hormonal effects. The portion of the stomach that is removed contains the majority of the cells that produce ghrelin — often referred to as the 'hunger hormone'. By reducing ghrelin levels, the procedure can decrease appetite, which supports longer-term weight management beyond simple portion control.

It is important to understand that a gastric sleeve is not a cosmetic procedure; it is a major surgical intervention indicated for people with clinically significant obesity. Although the operation itself is considered permanent and irreversible, conversion to another bariatric procedure (such as a Roux-en-Y gastric bypass) may occasionally be considered if clinically indicated — for example, in cases of refractory gastro-oesophageal reflux disease (GORD) or inadequate weight loss. This is distinct from gastric banding, which is adjustable and reversible.

One important consideration in patient selection is the effect of sleeve gastrectomy on GORD. The procedure can precipitate or worsen reflux symptoms, and in patients with severe pre-existing GORD or Barrett's oesophagus, a gastric bypass may be preferred. This is a recognised aspect of UK clinical practice and should be discussed during pre-operative assessment.

In the UK, sleeve gastrectomy is one of the most commonly performed bariatric procedures and is available through both the NHS and private healthcare providers. Patients considering this surgery should be fully informed of both the benefits and the risks before proceeding. Further information is available on the NHS.uk sleeve gastrectomy page and in NICE guideline CG189 (Obesity: identification, assessment and management).

Remi Bader, Body Image, and the Conversation Around Bariatric Surgery

Remi Bader has not definitively confirmed undergoing a gastric sleeve; public reporting more commonly references GLP-1 receptor agonist medication use. Her openness about binge eating disorder highlights the clinical importance of psychological support alongside any weight management intervention.

Remi Bader is an American model, content creator, and body positivity advocate who rose to prominence on TikTok and Instagram, known particularly for her 'realistic haul' fashion videos. She has been open with her audience about her struggles with binge eating disorder and her complex relationship with food and body image, and has publicly discussed her experiences with weight management interventions.

It is important to note that the specific medical interventions Remi Bader has undergone have not been definitively confirmed in verifiable clinical detail. Public reporting has more commonly referenced her use of GLP-1 receptor agonist medication (such as semaglutide) rather than bariatric surgery. Accordingly, this article does not assert that she underwent a gastric sleeve procedure. Any individual seeking information about her personal health journey should refer to her own verified statements.

Nonetheless, the broader themes she has raised — including the psychological challenges of managing binge eating disorder alongside weight loss interventions, and the risk that physical treatments alone may not address the underlying behavioural and emotional drivers of disordered eating — are clinically well-documented and important. Research consistently shows that pre-existing eating disorders, including binge eating disorder, can persist or worsen following bariatric surgery if not adequately treated beforehand. This is why UK clinical pathways place significant emphasis on psychological assessment and support as part of the bariatric care pathway.

Her openness has contributed to wider public conversation about the intersection of weight management and mental health — a topic that healthcare professionals take seriously. The key clinical message is clear: any surgical or pharmacological intervention addresses only part of the picture, and psychological and behavioural support remains essential for safe and sustainable outcomes. Patients with concerns about disordered eating are encouraged to discuss these openly with their GP or bariatric team. Support is available from organisations such as Beat Eating Disorders (beateatingdisorders.org.uk).

Who Is Eligible for a Gastric Sleeve on the NHS?

NHS eligibility requires a BMI of 40 or above, or 35–39.9 with a significant obesity-related condition, following completion of a Tier 3 specialist weight management programme. Lower BMI thresholds apply for people of South Asian origin with recent-onset type 2 diabetes.

In England, access to bariatric surgery on the NHS is governed by NICE guideline CG189 (Obesity: identification, assessment and management), which sets out the clinical criteria for surgical referral. Bariatric surgery may be considered for adults who meet the following criteria:

• BMI of 40 or above, or

• BMI of 35–39.9 with a significant obesity-related condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea

• BMI of 30–34.9 with recent-onset type 2 diabetes, where surgery may be considered as an option (see also NICE guideline NG28, Type 2 diabetes in adults)

For people of South Asian or other high-risk ethnic backgrounds, lower BMI thresholds apply. For example, bariatric surgery may be considered at a BMI of 27.5 or above in adults of South Asian origin with recent-onset type 2 diabetes, reflecting the higher metabolic risk at lower BMI in these populations.

Candidates must also have:

• Engaged with and completed appropriate non-surgical weight management interventions, typically through a Tier 3 specialist weight management service before referral to a Tier 4 surgical service

• Been assessed as fit for anaesthesia and surgery

• Committed to long-term follow-up

• Undergone multidisciplinary team (MDT) assessment, which includes psychological input as appropriate

Regarding psychological assessment: NICE requires MDT assessment with psychological support and evaluation as part of the pathway. Patients with active, untreated eating disorders — including binge eating disorder — should receive appropriate psychological treatment before being considered for surgery. This is not intended to exclude people with mental health histories, but to ensure the best possible outcomes and patient safety.

Eligibility criteria and waiting times may vary between NHS trusts and integrated care boards (ICBs). Patients are encouraged to speak with their GP as the first point of contact to begin the referral process and to discuss the Tier 3/4 pathway in their local area.

Risks, Benefits, and Long-Term Outcomes of the Procedure

Sleeve gastrectomy is associated with significant improvements in type 2 diabetes, hypertension, and sleep apnoea, but carries risks including GORD, nutritional deficiencies, and gallstone formation. Lifelong supplementation and annual blood monitoring are required.

The gastric sleeve offers well-documented clinical benefits for people with obesity. Studies consistently show that patients can expect to lose 50–70% of their excess body weight within the first 12–18 months following surgery. Beyond weight loss, the procedure is associated with significant improvements in obesity-related conditions, including:

• Type 2 diabetes — remission or improved glycaemic control in many patients

• Hypertension — reduced blood pressure and medication requirements

• Obstructive sleep apnoea — resolution or improvement in symptoms

• Joint pain and mobility — reduced load on weight-bearing joints

• Cardiovascular risk — improved lipid profiles and reduced long-term risk

However, as with any major surgery, there are risks that must be carefully considered. Short-term surgical risks include bleeding, infection, leakage from the staple line, stricture or stenosis, and blood clots (deep vein thrombosis or pulmonary embolism). Rapid weight loss in the months following surgery also increases the risk of gallstone formation, and some patients may require prophylactic treatment.

A particularly important longer-term risk is gastro-oesophageal reflux disease (GORD). Sleeve gastrectomy can cause or worsen reflux, and patients with significant pre-existing GORD or Barrett's oesophagus may be better suited to a gastric bypass. This should be discussed thoroughly during pre-operative assessment.

Other longer-term risks include nutritional deficiencies — particularly of vitamin B12, iron, calcium, vitamin D, folate, and, in cases of persistent vomiting, thiamine (vitamin B1). Patients are typically advised to take lifelong vitamin and mineral supplements and to attend regular follow-up appointments for blood monitoring. Per BOMSS (British Obesity and Metabolic Surgery Society) guidance, annual blood tests are recommended, including full blood count, ferritin, B12, folate, vitamin D, calcium, parathyroid hormone (PTH), and renal and liver function. Specific supplementation regimens — including a complete multivitamin with iron, calcium and vitamin D, and vitamin B12 (often as three-monthly injections) — should be agreed with the bariatric team.

Patients should also be aware of the potential for disordered eating behaviours to persist or emerge following surgery. It is important that patients have realistic expectations: the gastric sleeve is a powerful tool, but it requires sustained lifestyle changes and ongoing support to achieve and maintain results.

Life After a Gastric Sleeve: Diet, Lifestyle, and Support

Post-operative recovery involves a staged dietary progression from liquids to solids over six to eight weeks, with lifelong dietary changes including protein-first eating, hydration between meals, and prescribed nutritional supplements. NSAIDs should generally be avoided, and women should delay pregnancy for at least 12–18 months.

Recovery from a gastric sleeve typically involves a staged dietary progression over several weeks. Immediately post-operatively, patients follow a liquid-only diet, progressing to pureed foods, then soft foods, before gradually reintroducing solid meals. This process usually takes around six to eight weeks and is guided by a specialist dietitian. Long-term dietary habits must change significantly:

• Smaller, more frequent meals — typically three small meals per day, eating slowly and chewing thoroughly

• Protein-first approach — aiming for approximately 60–80 g of protein per day to support tissue healing and preserve muscle mass

• Staying well hydrated — aiming for approximately 1.5–2 litres of fluid per day, taken between meals rather than with them

• Avoiding fizzy (carbonated) drinks — which can cause discomfort and distension

• Limiting alcohol — which is absorbed more rapidly after surgery and carries increased risk of dependency

• Avoiding high-sugar foods — which can cause nausea and discomfort; note that 'dumping syndrome' (rapid gastric emptying causing sweating, palpitations, and diarrhoea) is more commonly associated with gastric bypass than with sleeve gastrectomy, though some symptoms of intolerance to high-sugar foods can occur after sleeve

• Taking prescribed nutritional supplements — lifelong, as directed by the bariatric team

Important medication and lifestyle considerations include:

• NSAIDs (such as ibuprofen) should generally be avoided where possible after bariatric surgery, as they increase the risk of ulceration; discuss any pain management needs with your GP or bariatric team

• A proton pump inhibitor (PPI) is commonly prescribed in the early post-operative period to reduce reflux and protect the stomach lining

• Smoking cessation is strongly advised before and after surgery, as smoking impairs healing and increases surgical risk

Pregnancy and contraception: Women of childbearing age should be advised to avoid pregnancy for at least 12–18 months following bariatric surgery, during the period of rapid weight loss and nutritional flux. Effective contraception should be used during this time, and nutritional status should be optimised before any planned pregnancy. Oral contraceptives may be less reliably absorbed in the early post-operative period; discuss contraceptive options with your GP.

Physical activity is strongly encouraged as part of long-term weight maintenance. Patients are typically advised to build up gradually from gentle walking to more structured exercise over the months following surgery.

Psychological support is a cornerstone of post-operative care. Surgery alone does not address the emotional or behavioural aspects of eating. Many NHS bariatric programmes offer access to psychological support before and after surgery. Patients who notice signs of disordered eating, low mood, or anxiety following their procedure should speak to their GP or bariatric team promptly.

When to seek urgent help: Contact your bariatric team or go to A&E immediately if you experience any of the following after surgery:

• Severe or worsening abdominal pain

• Rapid heart rate (tachycardia) or feeling faint

• Fever or signs of infection

• Chest pain or shortness of breath

• Calf pain or swelling (possible DVT)

• Persistent vomiting or inability to keep fluids down

• Signs of gastrointestinal bleeding (vomiting blood or passing black, tarry stools)

If you suspect a problem with a medicine or medical device used during your care, you can report this via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Where to Seek Advice About Weight Loss Surgery in the UK

The first step is to speak with your GP, who can assess eligibility and refer you to a Tier 3 specialist weight management service. Reputable sources include NHS.uk, NICE, BOMSS, and Beat Eating Disorders.

If you are considering weight loss surgery in the UK, the most appropriate first step is to speak with your GP. Your GP can assess whether you meet the initial eligibility criteria, discuss non-surgical options, and refer you to a Tier 3 specialist weight management service if appropriate. Completion of a Tier 3 programme is typically required before referral to a Tier 4 surgical service. Be prepared to discuss your full medical history, any previous weight management attempts, and your mental health history, as all of these are relevant to the assessment process.

For those considering private treatment, it is essential to choose a provider regulated by the appropriate body for your nation:

• England: Care Quality Commission (CQC) — cqc.org.uk

• Scotland: Healthcare Improvement Scotland (HIS) — healthcareimprovementscotland.org

• Wales: Healthcare Inspectorate Wales (HIW) — hiw.org.uk

• Northern Ireland: Regulation and Quality Improvement Authority (RQIA) — rqia.org.uk

Reputable private providers will follow the same clinical standards as NHS services, including multidisciplinary assessment and long-term follow-up. Be cautious of providers who offer surgery without thorough pre-operative evaluation, as this may compromise patient safety.

Useful and reliable sources of information include:

• NHS.uk — for general information on bariatric surgery, eligibility, risks, and recovery (search 'weight loss surgery')

• NICE (nice.org.uk) — NICE CG189 (Obesity: identification, assessment and management) and NICE NG28 (Type 2 diabetes in adults) for clinical guidance

• British Obesity and Metabolic Surgery Society (BOMSS) — bomss.org — the professional body for bariatric surgeons in the UK, with patient information on surgery, diet, supplementation, and follow-up

• Beat Eating Disorders (beateatingdisorders.org.uk) — for support if you have concerns about disordered eating

• MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) — to report suspected problems with medicines or medical devices

If you are experiencing significant distress related to your weight, eating behaviours, or body image, please do not hesitate to contact your GP or a mental health professional. Weight loss surgery can be life-changing when undertaken with the right support, but informed decision-making and ongoing care are essential to achieving safe and lasting outcomes.

Frequently Asked Questions